Evidence map›Paper›PMID 29118740›Full record

ArticleFrontiers in microbiology2017

Response to

Sandra C H Lonien, Aparecida D Malvezi, Helena T Suzukawa, Lucy M Yamauchi, Sueli F Yamada-Ogatta, Luiz V Rizzo, Juliano Bordignon, Phileno Pinge-Filho

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Towards a map of the immune system manipulation network byFrontiers in cellular and infection microbiology · 2025
    Review
  2. Article
  3. Article
  4. Cyclooxygenase (COX)-2 Inhibitors ReduceFrontiers in microbiology · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sandra C H LonienLaboratório de Imunopatologia Experimental, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Brazil.
Aparecida D MalveziLaboratório de Imunopatologia Experimental, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Brazil.
Helena T SuzukawaLaboratório de Imunopatologia Experimental, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Brazil.
Lucy M YamauchiLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Brazil.
Sueli F Yamada-OgattaLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Brazil.
Luiz V RizzoHospital Israelita Albert Einstein, São Paulo, Brazil.
Juliano BordignonLaboratório de Virologia Molecular, Instituto Carlos Chagas/Fiocruz, Curitiba, Brazil.
Phileno Pinge-FilhoLaboratório de Imunopatologia Experimental, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Brazil.
Universidade Estadual de Londrina · BRFundação Carlos Chagas · BRHospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease (Cd) or American human trypanosomiasis is caused by

Indexed as

aspirincelecoxibcell invasionhuman monocyte-derived dendritic cellsTrypanosoma cruzi

Identifiers

PMID29118740
PMCPMC5660982
OpenAlexW2767198447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.